25 XP   0   0   10

BIOLASE Inc
Buy, Hold or Sell?

Let's analyse Biolase together

PenkeI guess you are interested in BIOLASE Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BIOLASE Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BIOLASE Inc

I send you an email if I find something interesting about BIOLASE Inc.

Quick analysis of Biolase (30 sec.)










What can you expect buying and holding a share of Biolase? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$-0.01
Expected worth in 1 year
$-0.64
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-0.63
Return On Investment
-426.8%

For what price can you sell your share?

Current Price per Share
$0.15
Expected price per share
$0.1251 - $1.07
How sure are you?
50%

1. Valuation of Biolase (5 min.)




Live pricePrice per Share (EOD)

$0.15

Intrinsic Value Per Share

$-5.73 - $-4.68

Total Value Per Share

$-5.73 - $-4.69

2. Growth of Biolase (5 min.)




Is Biolase growing?

Current yearPrevious yearGrowGrow %
How rich?-$247k$4.8m-$5.1m-2,079.4%

How much money is Biolase making?

Current yearPrevious yearGrowGrow %
Making money-$20.6m-$28.6m$8m38.8%
Net Profit Margin-42.0%-59.1%--

How much money comes from the company's main activities?

3. Financial Health of Biolase (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#307 / 334

Most Revenue
#178 / 334

Most Profit
#220 / 334

Most Efficient
#203 / 334

What can you expect buying and holding a share of Biolase? (5 min.)

Welcome investor! Biolase's management wants to use your money to grow the business. In return you get a share of Biolase.

What can you expect buying and holding a share of Biolase?

First you should know what it really means to hold a share of Biolase. And how you can make/lose money.

Speculation

The Price per Share of Biolase is $0.148. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biolase.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biolase, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.01. Based on the TTM, the Book Value Change Per Share is $-0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.62 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biolase.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.63-428.6%-0.63-428.6%-0.88-594.9%-0.73-490.4%-0.67-451.1%
Usd Book Value Change Per Share-0.16-106.7%-0.16-106.7%-0.62-422.1%-0.07-47.1%-0.03-18.1%
Usd Dividend Per Share0.000.0%0.000.0%0.014.5%0.1175.4%0.0637.7%
Usd Total Gains Per Share-0.16-106.7%-0.16-106.7%-0.62-417.6%0.0428.3%0.0319.6%
Usd Price Per Share1.12-1.12-0.65-0.63-0.94-
Price to Earnings Ratio-1.77--1.77--0.74--0.93--1.53-
Price-to-Total Gains Ratio-7.10--7.10--1.05--1.71--2.33-
Price to Book Ratio-147.73--147.73-4.32--18.78--8.53-
Price-to-Total Gains Ratio-7.10--7.10--1.05--1.71--2.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.148
Number of shares6756
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.11
Usd Book Value Change Per Share-0.16-0.07
Usd Total Gains Per Share-0.160.04
Gains per Quarter (6756 shares)-1,066.91282.72
Gains per Year (6756 shares)-4,267.661,130.90
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-4268-42783015-18841121
20-8535-85466030-37682252
30-12803-128149044-56523383
40-17071-1708212059-75364514
50-21338-2135015074-94195645
60-25606-2561818089-113036776
70-29874-2988621103-131877907
80-34141-3415424118-150719038
90-38409-3842227133-1695510169
100-42677-4269030148-1883911300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%2.030.00.06.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%13.018.01.040.6%
Dividend per Share0.00.01.00.0%2.00.01.066.7%3.00.02.060.0%3.00.07.030.0%7.00.025.021.9%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%14.018.00.043.8%

Fundamentals of Biolase

About BIOLASE Inc

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Fundamental data was last updated by Penke on 2024-04-11 02:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BIOLASE Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biolase earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • A Net Profit Margin of -42.0% means that $-0.42 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BIOLASE Inc:

  • The MRQ is -42.0%. The company is making a huge loss. -2
  • The TTM is -42.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-42.0%TTM-42.0%0.0%
TTM-42.0%YOY-59.1%+17.1%
TTM-42.0%5Y-52.7%+10.7%
5Y-52.7%10Y-45.7%-7.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.0%-11.2%-30.8%
TTM-42.0%-20.4%-21.6%
YOY-59.1%-13.4%-45.7%
5Y-52.7%-21.0%-31.7%
10Y-45.7%-24.9%-20.8%
1.1.2. Return on Assets

Shows how efficient Biolase is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • -58.8% Return on Assets means that Biolase generated $-0.59 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BIOLASE Inc:

  • The MRQ is -58.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -58.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-58.8%TTM-58.8%0.0%
TTM-58.8%YOY-75.0%+16.2%
TTM-58.8%5Y-52.0%-6.8%
5Y-52.0%10Y-47.2%-4.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-58.8%-4.0%-54.8%
TTM-58.8%-4.7%-54.1%
YOY-75.0%-4.3%-70.7%
5Y-52.0%-3.9%-48.1%
10Y-47.2%-4.9%-42.3%
1.1.3. Return on Equity

Shows how efficient Biolase is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • 0.0% Return on Equity means Biolase generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BIOLASE Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-585.7%+585.7%
TTM-5Y-1,110.7%+1,110.7%
5Y-1,110.7%10Y-600.1%-510.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.1%+4.1%
TTM--5.7%+5.7%
YOY-585.7%-5.2%-580.5%
5Y-1,110.7%-6.1%-1,104.6%
10Y-600.1%-6.9%-593.2%

1.2. Operating Efficiency of BIOLASE Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biolase is operating .

  • Measures how much profit Biolase makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • An Operating Margin of -36.5% means the company generated $-0.36  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BIOLASE Inc:

  • The MRQ is -36.5%. The company is operating very inefficient. -2
  • The TTM is -36.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-36.5%TTM-36.5%0.0%
TTM-36.5%YOY-52.3%+15.8%
TTM-36.5%5Y-50.5%+14.0%
5Y-50.5%10Y-44.1%-6.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.5%-24.3%-12.2%
TTM-36.5%-16.7%-19.8%
YOY-52.3%-13.7%-38.6%
5Y-50.5%-19.9%-30.6%
10Y-44.1%-24.5%-19.6%
1.2.2. Operating Ratio

Measures how efficient Biolase is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.36 means that the operating costs are $1.36 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BIOLASE Inc:

  • The MRQ is 1.365. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.365. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.365TTM1.3650.000
TTM1.365YOY1.523-0.158
TTM1.3655Y1.505-0.140
5Y1.50510Y1.439+0.067
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3651.442-0.077
TTM1.3651.437-0.072
YOY1.5231.425+0.098
5Y1.5051.427+0.078
10Y1.4391.373+0.066

1.3. Liquidity of BIOLASE Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biolase is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.26 means the company has $1.26 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BIOLASE Inc:

  • The MRQ is 1.264. The company is just able to pay all its short-term debts.
  • The TTM is 1.264. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.264TTM1.2640.000
TTM1.264YOY1.626-0.362
TTM1.2645Y2.126-0.862
5Y2.12610Y2.300-0.173
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2642.691-1.427
TTM1.2642.724-1.460
YOY1.6263.496-1.870
5Y2.1263.619-1.493
10Y2.3003.487-1.187
1.3.2. Quick Ratio

Measures if Biolase is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • A Quick Ratio of 0.61 means the company can pay off $0.61 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BIOLASE Inc:

  • The MRQ is 0.613. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.613. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.613TTM0.6130.000
TTM0.613YOY0.563+0.050
TTM0.6135Y1.210-0.597
5Y1.21010Y1.384-0.174
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6131.503-0.890
TTM0.6131.663-1.050
YOY0.5632.142-1.579
5Y1.2102.307-1.097
10Y1.3842.313-0.929

1.4. Solvency of BIOLASE Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biolase assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biolase to Medical Devices industry mean.
  • A Debt to Asset Ratio of 1.01 means that Biolase assets are financed with 100.7% credit (debt) and the remaining percentage (100% - 100.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BIOLASE Inc:

  • The MRQ is 1.007. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.007. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.007TTM1.0070.000
TTM1.007YOY0.872+0.135
TTM1.0075Y0.833+0.174
5Y0.83310Y0.637+0.196
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0070.402+0.605
TTM1.0070.390+0.617
YOY0.8720.335+0.537
5Y0.8330.442+0.391
10Y0.6370.460+0.177
1.4.2. Debt to Equity Ratio

Measures if Biolase is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BIOLASE Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY6.811-6.811
TTM-5Y18.914-18.914
5Y18.91410Y9.952+8.962
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.562-0.562
TTM-0.564-0.564
YOY6.8110.480+6.331
5Y18.9140.622+18.292
10Y9.9520.685+9.267

2. Market Valuation of BIOLASE Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biolase generates.

  • Above 15 is considered overpriced but always compare Biolase to the Medical Devices industry mean.
  • A PE ratio of -1.77 means the investor is paying $-1.77 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BIOLASE Inc:

  • The EOD is -0.233. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.769. Based on the earnings, the company is expensive. -2
  • The TTM is -1.769. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.233MRQ-1.769+1.535
MRQ-1.769TTM-1.7690.000
TTM-1.769YOY-0.738-1.030
TTM-1.7695Y-0.934-0.835
5Y-0.93410Y-1.529+0.596
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.233-1.055+0.822
MRQ-1.769-1.715-0.054
TTM-1.769-2.213+0.444
YOY-0.738-2.977+2.239
5Y-0.934-2.300+1.366
10Y-1.529-1.932+0.403
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BIOLASE Inc:

  • The EOD is -0.313. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.369. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.369. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.313MRQ-2.369+2.057
MRQ-2.369TTM-2.3690.000
TTM-2.369YOY-0.693-1.676
TTM-2.3695Y-1.246-1.123
5Y-1.24610Y-1.953+0.707
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.313-0.882+0.569
MRQ-2.369-1.612-0.757
TTM-2.369-3.213+0.844
YOY-0.693-6.238+5.545
5Y-1.246-5.513+4.267
10Y-1.953-5.292+3.339
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biolase is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -147.73 means the investor is paying $-147.73 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BIOLASE Inc:

  • The EOD is -19.487. Based on the equity, the company is expensive. -2
  • The MRQ is -147.734. Based on the equity, the company is expensive. -2
  • The TTM is -147.734. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.487MRQ-147.734+128.247
MRQ-147.734TTM-147.7340.000
TTM-147.734YOY4.324-152.058
TTM-147.7345Y-18.775-128.959
5Y-18.77510Y-8.530-10.245
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-19.4872.025-21.512
MRQ-147.7342.380-150.114
TTM-147.7342.469-150.203
YOY4.3243.195+1.129
5Y-18.7753.955-22.730
10Y-8.5304.321-12.851
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of BIOLASE Inc.

3.1. Institutions holding BIOLASE Inc

Institutions are holding 8.237% of the shares of BIOLASE Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Anson Funds Management LP0.96450.0257185127133846261.0051
2023-12-31BlackRock Inc0.130302501800
2023-12-31Kellett Schaffner Wealth Advisors LLC0.09930.015919060190600
2023-12-31Zhang Financial LLC0.07170.001313770169214.0089
2023-12-31Virtu Financial LLC0.0640.001112289122890
2023-12-31Vanguard Group Inc0.0568010911109110
2023-12-31Two Sigma Investments LLC0.0559010726107260
2023-12-31UBS Group AG0.02930561556150
2023-12-31Tower Research Capital LLC0.01270244783351.6109
2023-12-31Advisor Group Holdings, Inc.0.000305000
2023-12-31Bank of America Corp0.0001023-18-43.9024
2023-12-31Wells Fargo & Co0.000101810125
2023-12-31Morgan Stanley - Brokerage Accounts0.0001014-3-17.6471
2023-12-31Huntington National Bank00100
2023-09-30Perkins Capital Management Inc000-1572-100
2023-09-30Honkamp Krueger Financial Services Inc000-5441-100
2023-12-31Walleye Trading Advisors, LLC000-16934-100
2023-09-30CoreCap Advisors, LLC00000
Total 1.48510.044285069+171014+60.0%

3.2. Funds holding BIOLASE Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BlackRock Extended Mkt Composite0.07380.0003240112383613620.5714
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.033501091100
2024-02-29Fidelity Extended Market Index0.01660538700
2024-02-29Fidelity Series Total Market Index0.00620202600
2023-12-31Northern Trust Extended Eq Market Idx0.0007023500
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0007023500
2024-02-29Fidelity Total Market Index0.0003010700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.000205500
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.000104400
2024-02-29Spartan Total Market Index Pool E0.000102400
2024-02-29Spartan Extended Market Index Pool E001500
2024-03-31BlackRock U.S. Equity Market F00700
2023-12-31NT US Market Cap Idx Fd - L00600
2023-12-31Northern Trust Wilshire 5000006-648-99.0826
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 500200
2023-06-30State St US Ttl Mkt Indx SL Cl I00200
2024-03-31State St US Extended Mkt Indx NL Cl C00110
2023-12-31SSgA U.S. Extended Market Index Class I00100
Total 0.13220.000343075+23189+53.8%

3.3. Insider Transactions

Insiders are holding 0.335% of the shares of BIOLASE Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-02-11Education Foundation SchulerBUY1307961
2022-12-07Jonathan T Md LordSELL3575
2021-12-15Jonathan T Md LordSELL11038
2021-11-30John R BeaverBUY70045
2021-08-20John R. BeaverBUY35061
2021-05-19John R BeaverBUY40075

4. Summary

4.1. Key Performance Indicators

The key performance indicators of BIOLASE Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.158-0.1580%-0.625+296%-0.070-56%-0.027-83%
Book Value Per Share---0.008-0.0080%0.150-105%0.248-103%0.522-101%
Current Ratio--1.2641.2640%1.626-22%2.126-41%2.300-45%
Debt To Asset Ratio--1.0071.0070%0.872+15%0.833+21%0.637+58%
Debt To Equity Ratio----0%6.811-100%18.914-100%9.952-100%
Dividend Per Share----0%0.007-100%0.112-100%0.056-100%
Eps---0.634-0.6340%-0.880+39%-0.726+14%-0.668+5%
Free Cash Flow Per Share---0.474-0.4740%-0.937+98%-0.548+16%-0.526+11%
Free Cash Flow To Equity Per Share--0.0620.0620%-0.796+1374%-0.013+121%0.015+318%
Gross Profit Margin--1.8941.8940%1.757+8%1.815+4%1.880+1%
Intrinsic Value_10Y_max---4.679--------
Intrinsic Value_10Y_min---5.727--------
Intrinsic Value_1Y_max---0.515--------
Intrinsic Value_1Y_min---0.636--------
Intrinsic Value_3Y_max---1.512--------
Intrinsic Value_3Y_min---1.869--------
Intrinsic Value_5Y_max---2.466--------
Intrinsic Value_5Y_min---3.046--------
Market Cap4813344.800-658%36490357.20036490357.2000%21139690.000+73%20368253.928+79%30632711.714+19%
Net Profit Margin---0.420-0.4200%-0.591+41%-0.527+26%-0.457+9%
Operating Margin---0.365-0.3650%-0.523+43%-0.505+38%-0.441+21%
Operating Ratio--1.3651.3650%1.523-10%1.505-9%1.439-5%
Pb Ratio-19.487+87%-147.734-147.7340%4.324-3517%-18.775-87%-8.530-94%
Pe Ratio-0.233+87%-1.769-1.7690%-0.738-58%-0.934-47%-1.529-14%
Price Per Share0.148-658%1.1221.1220%0.650+73%0.626+79%0.942+19%
Price To Free Cash Flow Ratio-0.313+87%-2.369-2.3690%-0.693-71%-1.246-47%-1.953-18%
Price To Total Gains Ratio-0.937+87%-7.105-7.1050%-1.052-85%-1.705-76%-2.334-67%
Quick Ratio--0.6130.6130%0.563+9%1.210-49%1.384-56%
Return On Assets---0.588-0.5880%-0.750+28%-0.520-12%-0.472-20%
Return On Equity----0%-5.8570%-11.1070%-6.0010%
Total Gains Per Share---0.158-0.1580%-0.618+291%0.042-477%0.029-646%
Usd Book Value---247000.000-247000.0000%4889000.000-105%8051000.000-103%16965000.000-101%
Usd Book Value Change Per Share---0.158-0.1580%-0.625+296%-0.070-56%-0.027-83%
Usd Book Value Per Share---0.008-0.0080%0.150-105%0.248-103%0.522-101%
Usd Dividend Per Share----0%0.007-100%0.112-100%0.056-100%
Usd Eps---0.634-0.6340%-0.880+39%-0.726+14%-0.668+5%
Usd Free Cash Flow---15402000.000-15402000.0000%-30488000.000+98%-17830200.000+16%-17105000.000+11%
Usd Free Cash Flow Per Share---0.474-0.4740%-0.937+98%-0.548+16%-0.526+11%
Usd Free Cash Flow To Equity Per Share--0.0620.0620%-0.796+1374%-0.013+121%0.015+318%
Usd Market Cap4813344.800-658%36490357.20036490357.2000%21139690.000+73%20368253.928+79%30632711.714+19%
Usd Price Per Share0.148-658%1.1221.1220%0.650+73%0.626+79%0.942+19%
Usd Profit---20632000.000-20632000.0000%-28634000.000+39%-20021600.000-3%-19305000.000-6%
Usd Revenue--49164000.00049164000.0000%48462000.000+1%39478600.000+25%43841500.000+12%
Usd Total Gains Per Share---0.158-0.1580%-0.618+291%0.042-477%0.029-646%
 EOD+2 -6MRQTTM+0 -0YOY+26 -95Y+19 -1610Y+19 -16

4.2. Fundamental Score

Let's check the fundamental score of BIOLASE Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.233
Price to Book Ratio (EOD)Between0-1-19.487
Net Profit Margin (MRQ)Greater than0-0.420
Operating Margin (MRQ)Greater than0-0.365
Quick Ratio (MRQ)Greater than10.613
Current Ratio (MRQ)Greater than11.264
Debt to Asset Ratio (MRQ)Less than11.007
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.588
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of BIOLASE Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.907
Ma 20Greater thanMa 500.155
Ma 50Greater thanMa 1000.151
Ma 100Greater thanMa 2000.556
OpenGreater thanClose0.150
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Total Stockholder Equity 3779,65110,02815,18025,208-20,3194,889-5,136-247



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets35,101
Total Liabilities35,348
Total Stockholder Equity-247
 As reported
Total Liabilities 35,348
Total Stockholder Equity+ -247
Total Assets = 35,101

Assets

Total Assets35,101
Total Current Assets24,863
Long-term Assets10,238
Total Current Assets
Cash And Cash Equivalents 6,566
Net Receivables 5,483
Inventory 11,433
Other Current Assets 1,381
Total Current Assets  (as reported)24,863
Total Current Assets  (calculated)24,863
+/-0
Long-term Assets
Property Plant Equipment 7,044
Goodwill 2,926
Long-term Assets Other 268
Long-term Assets  (as reported)10,238
Long-term Assets  (calculated)10,238
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities19,663
Long-term Liabilities15,685
Total Stockholder Equity-247
Total Current Liabilities
Short-term Debt 3,153
Short Long Term Debt 2,265
Accounts payable 6,065
Other Current Liabilities 7,993
Total Current Liabilities  (as reported)19,663
Total Current Liabilities  (calculated)19,476
+/- 187
Long-term Liabilities
Long term Debt 11,782
Capital Lease Obligations 1,660
Long-term Liabilities Other 79
Long-term Liabilities  (as reported)15,685
Long-term Liabilities  (calculated)13,521
+/- 2,164
Total Stockholder Equity
Common Stock3
Retained Earnings -316,800
Other Stockholders Equity 314,900
Total Stockholder Equity (as reported)-247
Total Stockholder Equity (calculated)-1,897
+/- 1,650
Other
Capital Stock2,206
Cash and Short Term Investments 6,566
Common Stock Shares Outstanding 1,278
Current Deferred Revenue2,452
Liabilities and Stockholders Equity 35,101
Net Debt 11,344
Net Invested Capital 13,800
Net Working Capital 5,200
Property Plant and Equipment Gross 18,374
Short Long Term Debt Total 17,910



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-31
> Total Assets 
5,600
5,100
2,400
2,500
4,700
3,400
3,900
2,672
6,599
7,561
14,395
44,501
58,746
58,746
48,578
44,308
35,708
22,177
18,147
29,807
31,973
31,038
59,403
42,251
41,941
42,984
38,516
31,847
41,025
55,284
38,186
35,101
35,10138,18655,28441,02531,84738,51642,98441,94142,25159,40331,03831,97329,80718,14722,17735,70844,30848,57858,74658,74644,50114,3957,5616,5992,6723,9003,4004,7002,5002,4005,1005,600
   > Total Current Assets 
3,700
2,900
1,900
2,200
4,400
3,000
3,300
2,280
4,162
6,912
12,550
23,296
51,095
51,095
38,989
35,776
28,794
16,412
13,943
25,326
26,917
25,854
54,798
34,800
33,987
36,050
33,307
27,019
35,110
49,354
28,959
24,863
24,86328,95949,35435,11027,01933,30736,05033,98734,80054,79825,85426,91725,32613,94316,41228,79435,77638,98951,09551,09523,29612,5506,9124,1622,2803,3003,0004,4002,2001,9002,9003,700
       Cash And Cash Equivalents 
1,300
2,000
1,200
1,600
300
200
400
1,181
2,002
2,670
3,940
11,111
6,140
6,140
14,676
14,566
11,235
2,975
1,694
3,307
2,543
1,440
31,560
11,699
8,924
11,645
8,044
5,789
17,564
29,972
4,181
6,566
6,5664,18129,97217,5645,7898,04411,6458,92411,69931,5601,4402,5433,3071,6942,97511,23514,56614,6766,1406,14011,1113,9402,6702,0021,1814002003001,6001,2002,0001,300
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
25,326
25,326
0
0
0
0
0
0
0
0
0
200
251
251
0
0
0
0
0
0
00000025125120000000000025,32625,326000000000000
       Net Receivables 
1,200
200
100
100
100
1,100
600
331
758
2,095
4,790
5,771
9,635
9,635
15,193
11,266
3,758
4,229
3,331
8,899
11,680
11,127
9,004
8,948
9,784
10,124
11,112
8,760
3,059
4,238
5,841
5,483
5,4835,8414,2383,0598,76011,11210,1249,7848,9489,00411,12711,6808,8993,3314,2293,75811,26615,1939,6359,6355,7714,7902,0957583316001,1001001001002001,200
       Inventory 
1,100
600
600
400
400
1,000
1,900
658
1,222
1,887
2,792
3,752
8,180
8,180
7,774
7,627
12,410
7,861
6,987
11,312
11,142
11,378
12,508
12,566
13,523
12,298
12,248
10,995
11,157
12,929
15,884
11,433
11,43315,88412,92911,15710,99512,24812,29813,52312,56612,50811,37811,14211,3126,9877,86112,4107,6277,7748,1808,1803,7522,7921,8871,2226581,9001,0004004006006001,100
       Other Current Assets 
100
100
0
100
3,600
700
400
110
180
260
1,028
55
1,814
1,814
1,346
2,317
1,391
1,347
576
1,808
1,552
1,909
1,726
1,387
1,505
1,732
1,591
1,163
3,018
2,012
3,053
1,381
1,3813,0532,0123,0181,1631,5911,7321,5051,3871,7261,9091,5521,8085761,3471,3912,3171,3461,8141,814551,0282601801104007003,6001000100100
   > Long-term Assets 
1,900
2,200
500
300
300
400
600
392
2,437
649
1,845
21,205
7,651
7,651
9,589
8,532
6,914
5,765
4,204
4,481
5,056
5,184
4,605
7,451
7,954
6,934
5,209
4,828
5,915
5,930
9,227
10,238
10,2389,2275,9305,9154,8285,2096,9347,9547,4514,6055,1845,0564,4814,2045,7656,9148,5329,5897,6517,65121,2051,8456492,4373926004003003005002,2001,900
       Property Plant Equipment 
1,100
900
400
300
200
200
400
204
2,329
392
1,733
1,973
3,025
3,025
4,851
4,040
3,040
2,180
755
1,148
1,509
1,826
1,295
3,727
4,478
3,674
1,975
1,469
2,758
2,784
6,046
7,044
7,0446,0462,7842,7581,4691,9753,6744,4783,7271,2951,8261,5091,1487552,1803,0404,0404,8513,0253,0251,9731,7333922,3292044002002003004009001,100
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
2,926,000
2,926
2,926,000
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,926,0002,9262,926,00000000000000
       Intangible Assets 
600
1,100
0
0
0
100
100
127
104
91
67
5,513
4,588
4,588
1,469
1,208
613
472
342
212
300
183
114
51
2,926
2,926
0
0
0
0
0
0
0000002,9262,926511141833002123424726131,2081,4694,5884,5885,51367911041271001000001,100600
       Long-term Assets Other 
200
200
100
0
100
100
100
61
4
166
45
1,041
38
38
308
308
306
170
170
187
305
249
270
747
550
334
308
433
231
220
255
268
26825522023143330833455074727024930518717017030630830838381,041451664611001001000100200200
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
16
0
0
0
0
0
0
0
0
0
0
0
000000000001680000000000000000000
> Total Liabilities 
2,800
2,400
700
700
800
1,300
3,200
3,612
5,542
5,982
9,208
12,719
24,768
24,768
26,612
27,817
26,318
14,248
21,194
17,238
20,179
22,557
17,347
17,326
19,876
13,724
27,427
31,470
30,997
30,076
33,297
35,348
35,34833,29730,07630,99731,47027,42713,72419,87617,32617,34722,55720,17917,23821,19414,24826,31827,81726,61224,76824,76812,7199,2085,9825,5423,6123,2001,3008007007002,4002,800
   > Total Current Liabilities 
2,600
1,800
700
700
800
1,300
3,200
3,612
4,368
5,777
9,066
12,640
21,145
21,145
22,063
24,783
23,771
11,610
19,660
16,282
19,375
21,939
16,151
15,106
18,014
13,370
15,967
25,779
11,223
13,844
17,807
19,663
19,66317,80713,84411,22325,77915,96713,37018,01415,10616,15121,93919,37516,28219,66011,61023,77124,78322,06321,14521,14512,6409,0665,7774,3683,6123,2001,3008007007001,8002,600
       Short-term Debt 
300
500
0
0
0
300
1,700
1,342
1,812
1,792
3,012
2,680
0
11,467
0
3,552
5,404
0
2,622
2,622
1,637
4,633
0
167
159
0
21
13,466
305
405
700
3,153
3,15370040530513,46621015916704,6331,6372,6222,62205,4043,552011,46702,6803,0121,7921,8121,3421,700300000500300
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
326
159
0
0
13,466
0
0
700
2,265
2,2657000013,4660015932600000000000000000000000
       Accounts payable 
1,200
300
100
0
100
500
800
792
946
1,656
2,082
3,590
7,147
7,147
7,699
6,151
7,509
4,887
4,029
7,804
7,663
8,560
8,357
5,960
9,125
5,109
5,953
5,332
2,651
3,309
5,786
6,065
6,0655,7863,3092,6515,3325,9535,1099,1255,9608,3578,5607,6637,8044,0294,8877,5096,1517,6997,1477,1473,5902,0821,65694679280050010001003001,200
       Other Current Liabilities 
1,100
1,000
600
700
700
500
700
1,478
1,609
353
-325,028
6,226
11,530
63
8,933
9,431
8,255
5,600
11,359
3,555
6,267
4,997
5,188
5,739
5,619
5,609
7,517
4,744
6,362
7,871
9,210
7,993
7,9939,2107,8716,3624,7447,5175,6095,6195,7395,1884,9976,2673,55511,3595,6008,2559,4318,9336311,5306,226-325,0283531,6091,4787005007007006001,0001,100
   > Long-term Liabilities 
200
600
100
0
100
800
2,500
2,134
1,175
205
142
79
3,623
3,623
4,549
3,034
2,547
2,638
1,534
956
804
618
1,196
2,220
1,862
354
11,460
5,691
19,774
16,232
15,490
15,685
15,68515,49016,23219,7745,69111,4603541,8622,2201,1966188049561,5342,6382,5473,0344,5493,6233,623791422051,1752,1342,5008001000100600200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
159
0
0
10,836
0
16,186
0
0
0
00016,186010,8360015900000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
16
0
0
0
0
0
0
0
0
0
0
0
000000000001680000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,965
0
0
0
0
00003,965000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
205
142
79
3,462
0
4,278
2,692
2,171
2,165
990
362
141
1
519
2,061
1,862
354
624
1,723
1,814
1,180
1,140
0
01,1401,1801,8141,7236243541,8622,06151911413629902,1652,1712,6924,27803,46279142205000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
619
666
618
0
880
821
115
77
436
374
0
0
0
0003744367711582188006186666190000000000000000000
> Total Stockholder Equity
2,800
2,700
1,700
1,800
3,900
2,100
700
-939
1,057
1,579
5,187
31,782
33,978
33,978
21,966
16,491
9,390
7,929
-3,047
12,569
11,794
8,481
42,056
24,925
22,065
29,260
11,089
377
10,028
25,208
4,889
-247
-2474,88925,20810,02837711,08929,26022,06524,92542,0568,48111,79412,569-3,0477,9299,39016,49121,96633,97833,97831,7825,1871,5791,057-9397002,1003,9001,8001,7002,7002,800
   Common Stock
0
0
0
0
0
0
0
18
19
20
20
22
25
25
26
26
27
27
27
33
34
38
58
58
68
102
21
31
98
154
8
3
381549831211026858583834332727272626252522202019180000000
   Retained Earnings -316,800-296,168-267,534-251,376-234,547-216,692-195,176-178,325-162,954-142,676-123,750-112,268-109,212-104,726-92,705-89,749-80,620-73,184-50,985-50,985-27,281-44,273-46,903-46,495-42,767-38,000-27,600-24,800-22,300-20,300-17,300-9,700
   Accumulated Other Comprehensive Income 
-600
-800
-800
-900
-1,000
-1,100
-1,200
-1,301
-249
-312
-57
-147
-225
-225
108
54
-187
-222
-324
-360
-320
-274
-557
-801
-876
-576
-670
-701
-385
-623
-733
-553
-553-733-623-385-701-670-576-876-801-557-274-320-360-324-222-18754108-225-225-147-57-312-249-1,301-1,200-1,100-1,000-900-800-800-600
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
138,507
140,747
148,866
185,231
188,622
201,198
224,910
228,430
235,594
261,573
0
0
0
000261,573235,594228,430224,910201,198188,622185,231148,866140,747138,5070000000000000000000
   Treasury Stock0000000000-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399000000000000
   Other Stockholders Equity 
13,100
20,800
22,800
25,000
29,700
30,800
39,900
43,111
47,781
48,774
49,497
59,188
85,163
85,163
95,016
97,031
99,299
100,829
101,976
122,108
124,348
132,467
185,231
188,622
201,198
224,910
228,430
231,629
261,573
293,177
301,782
314,900
314,900301,782293,177261,573231,629228,430224,910201,198188,622185,231132,467124,348122,108101,976100,82999,29997,03195,01685,16385,16359,18849,49748,77447,78143,11139,90030,80029,70025,00022,80020,80013,100



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue49,164
Cost of Revenue-32,440
Gross Profit16,72416,724
 
Operating Income (+$)
Gross Profit16,724
Operating Expense-34,661
Operating Income-17,937-17,937
 
Operating Expense (+$)
Research Development6,004
Selling General Administrative10,216
Selling And Marketing Expenses18,441
Operating Expense34,66134,661
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,361
Other Finance Cost-859
Net Interest Income-3,220
 
Pretax Income (+$)
Operating Income-17,937
Net Interest Income-3,220
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-20,601-15,273
EBIT - interestExpense = -20,298
-20,601
-18,271
Interest Expense2,361
Earnings Before Interest and Taxes (EBIT)-17,937-18,240
Earnings Before Interest and Taxes (EBITDA)-15,139
 
After tax Income (+$)
Income Before Tax-20,601
Tax Provision-132
Net Income From Continuing Ops-25,167-20,733
Net Income-20,632
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses67,101
Total Other Income/Expenses Net-2,6643,220
 

Technical Analysis of Biolase
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biolase. The general trend of Biolase is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biolase's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BIOLASE Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.257 < 1.07 < 1.07.

The bearish price targets are: 0.1255 > 0.1251.

Tweet this
BIOLASE Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BIOLASE Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BIOLASE Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BIOLASE Inc. The current macd is -0.01436506.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biolase price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biolase. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biolase price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BIOLASE Inc Daily Moving Average Convergence/Divergence (MACD) ChartBIOLASE Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BIOLASE Inc. The current adx is 13.72.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biolase shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
BIOLASE Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BIOLASE Inc. The current sar is 0.15891097.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BIOLASE Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BIOLASE Inc. The current rsi is 41.91. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
BIOLASE Inc Daily Relative Strength Index (RSI) ChartBIOLASE Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BIOLASE Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biolase price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BIOLASE Inc Daily Stochastic Oscillator ChartBIOLASE Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BIOLASE Inc. The current cci is -44.57105912.

BIOLASE Inc Daily Commodity Channel Index (CCI) ChartBIOLASE Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BIOLASE Inc. The current cmo is -6.85747421.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
BIOLASE Inc Daily Chande Momentum Oscillator (CMO) ChartBIOLASE Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BIOLASE Inc. The current willr is -44.71744472.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biolase is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BIOLASE Inc Daily Williams %R ChartBIOLASE Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BIOLASE Inc.

BIOLASE Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BIOLASE Inc. The current atr is 0.01855925.

BIOLASE Inc Daily Average True Range (ATR) ChartBIOLASE Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BIOLASE Inc. The current obv is 109,384,181.

BIOLASE Inc Daily On-Balance Volume (OBV) ChartBIOLASE Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BIOLASE Inc. The current mfi is 53.48.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
BIOLASE Inc Daily Money Flow Index (MFI) ChartBIOLASE Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BIOLASE Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

BIOLASE Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BIOLASE Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.907
Ma 20Greater thanMa 500.155
Ma 50Greater thanMa 1000.151
Ma 100Greater thanMa 2000.556
OpenGreater thanClose0.150
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biolase with someone you think should read this too:
  • Are you bullish or bearish on Biolase? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biolase? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BIOLASE Inc

I send you an email if I find something interesting about BIOLASE Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BIOLASE Inc.

Receive notifications about BIOLASE Inc in your mailbox!